Shares of Geron Corporation (GERN) tumbled 5.30% in pre-market trading on Wednesday, following the release of its first quarter 2025 financial results. Despite beating analyst estimates on some key metrics, investors appeared to focus on the company's continued net loss and high operating expenses.
Geron reported a Q1 EPS of -$0.03, surpassing the IBES estimate of -$0.04. The company's operating income came in at -$16.704 million, also better than the estimated -$23.5 million. However, these improvements were overshadowed by a substantial net loss of $19.835 million for the quarter.
A major concern for investors seems to be Geron's high operating expenses, which reached $56.307 million in Q1. This significant spending, likely related to ongoing research and development efforts, appears to be weighing heavily on the company's financial performance and investor sentiment. The pre-market plunge suggests that market participants may be growing impatient with the company's path to profitability, despite its progress in narrowing losses compared to analyst expectations.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。